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HUMAN DEVELOPMENT

RESEARCH ARTICLE

Young transposable elements rewired gene regulatory networks in
human and chimpanzee hippocampal intermediate progenitors

ABSTRACT
The hippocampus is associated with essential brain functions, such
as learning and memory. Human hippocampal volume is significantly
greater than expected compared with that of non-human apes,
suggesting a recent expansion. Intermediate progenitors, which are
able to undergo multiple rounds of proliferative division before a final
neurogenic division, may have played a role in evolutionary
hippocampal expansion. To investigate the evolution of gene
regulatory networks underpinning hippocampal neurogenesis in
apes, we leveraged the differentiation of human and chimpanzee
induced pluripotent stem cells into TBR2 (or EOMES)-positive
hippocampal intermediate progenitor cells (hpIPCs). We found that
the gene networks active in hpIPCs are significantly different between
humans and chimpanzees, with ∼2500 genes being differentially
expressed. We demonstrate that species-specific transposonderived enhancers contribute to these transcriptomic differences.
Young transposons, predominantly endogenous retroviruses and
SINE-Vntr-Alus (SVAs), were co-opted as enhancers in a speciesspecific manner. Human-specific SVAs provided substrates for
thousands of novel TBR2-binding sites, and CRISPR-mediated
repression of these SVAs attenuated the expression of ∼25% of the
genes that are upregulated in human intermediate progenitors relative
to the same cell population in the chimpanzee.
KEY WORDS: Hippocampal development, Transposable elements,
Induced pluripotent stem cells, Intermediate progenitors, TBR2,
SINE-Vntr-Alus

INTRODUCTION

The hippocampus is associated with many traits relevant in the
context of human evolution. These include traits such as tool use
and language, which require social cognition and learning, as well
as spatial memory, navigation and episodic memory (Burgess et al.,
2002; Eichenbaum, 2017a,b; Squire, 1992; Tomasello and
Herrmann, 2010). This region of the brain is also greatly affected
by Alzheimer’s Disease (AD), a neurodegenerative disorder
characterized by cell death, plaques and tangles of misfolded
proteins, and cognitive decline (Duyckaerts et al., 2009). It has been
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hypothesized that the cognitive AD phenotype is uniquely human
and that non-human primates, including chimpanzees, do not
exhibit AD-related dementia (Edler et al., 2017; Finch and Austad,
2015; Walker and Jucker, 2017). If humans are uniquely susceptible
to AD, it is crucial to understand how the human hippocampus
differs from that of our closest biological relatives, the chimpanzees.
Human hippocampal volume is 50% greater than expected
compared with the hippocampal volumes of non-human apes,
possibly indicating a recent hippocampal expansion specific to the
human lineage (Barger et al., 2014). However, the evolution of the
human hippocampus and the developmental mechanisms driving
the human-specific volume increase have not yet been thoroughly
studied.
Recent studies have suggested that evolutionary changes to
neuronal progenitors may have had an impact on cortical volume in
primates by increasing proliferative potential (Martínez-Cerdeño
et al., 2006; Rétaux et al., 2013; Florio and Huttner, 2014). A specific
class of neuronal progenitors known as intermediate progenitor cells
(IPCs) or ‘transit-amplifying cells’ are able to undergo multiple
rounds of proliferative division before a final neurogenic division
(Englund, 2005; Arnold et al., 2008; Pontious et al., 2008; Hevner,
2019). These cells express the neurodevelopmental transcription
factor TBR2 (EOMES) and are found in the sub-ventricular zone of
the developing neocortex and hippocampus (Bulfone et al., 1999;
Kimura et al., 1999; Englund, 2005; Cipriani et al., 2016). Genetic
ablation of TBR2 in these progenitors results in reduced cortical
thickness in mice (Sessa et al., 2008), abnormal cortical cell
differentiation (Mihalas et al., 2016) and impaired neurogenesis in
the hippocampal formation (Hodge et al., 2012). As these IPCs are
hypothesized to play a role in neocortical expansion, they may also be
involved in the lineage-specific hippocampal expansion seen in
humans.
Many of the differences between humans and chimpanzees are
due to diverging gene regulatory sequences (Agoglia et al., 2021;
Enard et al., 2002; Gokhman et al., 2021; King and Wilson, 1975;
Wray, 2007). A recent study comparing gene expression in adult
human, chimpanzee and macaque brain regions identified several
genes specifically upregulated in the human hippocampus (Sousa
et al., 2017). However, transcriptomic differences between primate
species during specific time points of hippocampal development
have not been investigated.
As samples of developing human and chimpanzee brain tissue are
extremely limited, induced pluripotent stem cells (iPSCs) are an
ideal system to conduct comparative studies of human and
chimpanzee hippocampal development. Previous studies have
employed iPSC-derived cortical organoids and iPSC-derived
neuronal progenitor cells (NPCs) from human and chimpanzee for
comparative and developmental genomic purposes (Marchetto
et al., 2019; Mora-Bermúdez et al., 2016). Here, we leverage
human and chimpanzee iPSC-derived hippocampal progenitors as
models for comparative developmental and genomic studies with
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the goal of identifying species-specific differences in gene
regulation during hippocampal development.
Several papers have recently demonstrated that transposable
elements (TEs) can alter existing regulatory elements or generate
entirely novel ones, as well as expand in a species- or lineagespecific manner (Sundaram et al., 2014; Playfoot et al., 2021;
Okhovat et al., 2020; Marnetto et al., 2018; reviewed by Sundaram
and Wysocka, 2020). Species-specific TE expansion and co-option
into gene regulatory networks have been demonstrated as a
mechanism for evolutionary change (Chuong et al., 2016; Fuentes
et al., 2018; Jacques et al., 2013; Lynch et al., 2011, 2015; Miao
et al., 2020; Mika et al., 2021; Pontis et al., 2019; Trizzino et al.,
2017). Endogenous retroviruses (ERVs) and SINE-Vntr-Alus
(SVAs) are among the TE families more frequently associated
with gene regulatory activity in the human genome (Chuong et al.,
2016; Fuentes et al., 2018; Pontis et al., 2019; Trizzino et al., 2017,
2018). SVAs encompass six subfamilies, denoted as SVA-A
through SVA-F. Of the ∼3000 SVA copies in the human genome,
nearly half are human specific, including those belonging to the
SVA-E and SVA-F subfamilies (Quinn and Bubb, 2014; Wang
et al., 2005). The remaining half are also found in other great apes.
SVAs are still replication competent and thus able to transpose in the
human genome. ERVs are retrotransposons belonging to the long
terminal repeat (LTR) group. They are remnants of past retroviral
infection events and make up ∼8% of the human genome
(Tokuyama et al., 2018). Both SVAs and ERVs were recently
found to be enriched within the sequences of active cis-regulatory
elements (enhancers and promoters) in hippocampal tissue
compared with other human brain regions in which they are
predominantly repressed (Trizzino et al., 2018). Therefore, we
hypothesize that species-specific ERV and SVA transposon activity
may influence the gene regulatory networks necessary for human
and chimpanzee hippocampal development.
Given the key function that IPCs played in the evolution of the
primate brain (Florio and Huttner, 2014; Martínez-Cerdeño et al.,
2006), we sought to identify molecular differences between iPSCderived human and chimpanzee hippocampal intermediate
progenitor cells (hpIPCs) in terms of gene expression and the
regulatory activity of non-coding regions. We specifically examined
gene expression [by RNA sequencing (RNA-seq) and single-cell
RNA-seq (scRNA-seq)], gene regulation [by assay for transposaseaccessible chromatin using sequencing (ATAC-seq)] and functional
TE activity via CRISPR interference.
We leveraged scRNA-seq to examine the temporal trajectory of
the hpIPCs during differentiation in both species. After confirming
that the hpIPC differentiated cells express the appropriate
neurodevelopmental markers, we conducted a transcriptomic
comparison between human and chimpanzee hpIPCs. This
analysis revealed over 2500 differentially expressed genes
(DEGs). We then used ATAC-seq to conduct extensive analyses
of differential chromatin accessibility between human and
chimpanzee hpIPCs. In both species, differentially accessible
(DA) chromatin regions were more likely than expected to overlap
a TE insertion. Furthermore, these regions were found to be both
enriched and depleted for specific TE families. Notably, speciesspecific enrichment for ERV and SVA sequences within
differentially accessible genomic sites correlated with speciesspecific changes in nearby gene expression. This is likely driven by
transcription factors binding to the TE-derived regulatory
sequences, as we demonstrate for TBR2 and SVA-derived
enhancers. Finally, we used CRISPR interference to repress all
the accessible SVAs in progenitor-like cells and demonstrated that
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such repression results in global changes in gene expression and
affects hundreds of important neurodevelopmental genes.
This work demonstrates that two young TE families have
contributed significantly to the gene regulatory differences
between human and chimpanzee hippocampal development,
providing insight into how the human hippocampus evolved both
its unique cognitive capacity and its susceptibility to
neurodegenerative disease.
RESULTS
An iPSC-derived model for human and chimpanzee hpIPCs

We modeled hpIPCs in humans and chimpanzees using three
human and three chimpanzee iPSC lines. All six iPSC lines
were validated as pluripotent in previous studies (Gallego Romero
et al., 2015; Pagliaroli et al., 2021; Pashos et al., 2017; Ward
et al., 2018; Yang et al., 2015; Zhang et al., 2015). For both human
and chimpanzee iPSCs, we used two female cell lines and one male
line.
We used a previously published method to generate hpIPCs
from iPSCs (Yu et al., 2014). In this protocol, the stem cells are
treated with a medium containing anticaudalizing factors and sonic
hedgehog antagonists (DKK1, Noggin and SB431542) to generate
forebrain progenitor cell types (Yu et al., 2014). It should be noted
that the hpIPCs are distinct from a more general neuronal progenitor
cell ( pan-NPC) as the pan-NPC medium is supplemented only with
FGF2 and B27. Moreover, the hpIPCs can be further induced to
generate mature hippocampal CA3 pyramidal or dentate gyrus
granule neurons (Sarkar et al., 2018; Yu et al., 2014).
As we were specifically interested in TBR2-positive hpIPCs, we
differentiated one human male and one chimpanzee male iPSC line
to ensure that differentiation proceeded similarly in each speciesspecific cell line and we compared the transcriptomes by conducting
scRNA-seq at 24 h intervals from the iPSC stage (day 0) to the
hpIPC stage (day 5). We assayed a total of 18,935 cells, with 4540
chimpanzee cells and 14,395 human cells. The scRNA-seq data
demonstrate that the differentiation follows a similar trajectory in
both species (Fig. 1A). Despite the difference in final cell number
between each species-specific cell line (Fig. S1A), all six time
points overlap closely between the species (Fig. S1B,C).
Chimpanzee cells from days 2 and 3 overlap more than expected
with human cells from days 3 and 4, respectively, suggesting that the
chimpanzee cells are further along in differentiation to hpIPCs at
these time points. However, both species align closely again by
day 5, which is the time point chosen for all the genomic analyses
conducted in the present study.
We further leveraged the scRNA-seq data to examine the
expression of known neurodevelopmental markers and saw a
progressive increase in the expression of both PAX6 and OTX2
during the 5-day differentiation (Fig. 1B,C), which remained
consistent between species (Fig. S1D,E). To investigate any
noticeable changes to the cell cycle or proliferation between
species, we quantified the number of cells at the G1, S and G2/M
phases of the cell cycle within the scRNA-seq dataset based on a set
of known cell cycle genes and did not detect significant differences
(Fig. 1E).
To ensure that the differentiation resulted in hpIPCs specifically,
we conducted western blotting for samples from both speciesspecific cell lines and confirmed that TBR2 expression in human
cells was greatest at days 4 and 5 (Fig. 1D), similarly to OTX2 and
PAX6 expression (Fig. 1B,C). In chimpanzee cells, TBR2 was
expressed as early as day 2, corroborating evidence from the
scRNA-seq data that chimpanzee differentiation initially proceeds
2
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faster. However, we did not see evidence that TBR2 expression in
chimpanzee cells was greater than TBR2 expression at day 5 in
human cells. As OTX2 labels neuronal progenitors and TBR2
and PAX6 mark the intermediate progenitor cell type (Florio
and Huttner, 2014; Cipriani et al., 2016; Hevner, 2019),
the data demonstrate that the differentiation was successful and
comparable between species. Lastly, we conducted chromatin
immunoprecipitation (ChIP) followed by sequencing (ChIP-seq)
against TBR2 and the active histone mark H3K27ac to determine
whether TBR2 was bound at the same genomic sites in both species
(Fig. 1F). We identified 3789 TBR2-bound regions in human
hpIPCs and observed that nearly all of them also exhibited
H3K27ac. Upon translating the coordinates of these regions to the
chimpanzee genome, we observed that the 3781 orthologous
regions were bound by TBR2 in chimpanzee hpIPCs. Together,
these data indicate that our iPSC-derived model is suitable to study
gene regulation within TBR2-positive hpIPCs from both human and
chimpanzee.
Important neurodevelopmental genes are differentially
expressed between human and chimpanzee hpIPCs

To investigate the differences between human and chimpanzee
hpIPCs, we first aimed to characterize differential gene expression

between the hpIPCs of the two species. After 5 days of treatment
with the hpIPC differentiation medium, we collected cells for RNA
extraction (Fig. 2A). To ensure statistical power, we conducted bulk
RNA-seq on two replicates each of all six cell lines (i.e. three
biological replicates and six technical replicates per species).
The differentiation, harvesting and RNA processing were performed
in mixed batches with samples from both species to prevent
batch effects. The libraries were sequenced using an Illumina
NextSeq500, generating 100 bp paired-end reads. Non-orthologous
genes were omitted from the analysis and a total of 2588 genes were
identified as being differentially expressed [false discovery rate
(FDR)<0.05 and log2(fold change)>1.5 or <−1.5]. The genes with
log2(fold change)>1.5 were more highly expressed in the human
hpIPCs (‘Human UP’), whereas the genes with log2(fold
change)<−1.5 were more highly expressed in the chimpanzee
hpIPCs (‘Chimp UP’). In total, 1686 (65.1%) of the DEGs were
‘Human UP’ and 901 (34.9%) of the DEGs were ‘Chimp UP’ genes
(Fig. 2B; Table S1).
Hippocampal neurodevelopmental markers PAX6, OTX2,
NEUROD1 and FOXG1 were found to be highly expressed
in both species (Figs 1B,C, 2B).
The ‘Human UP’ genes include FOXP2, MTRNR2L8, DHX40,
VPS13B, WDFY2 and PURB, all of which are associated with
3
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Fig. 1. Differentiation of human and chimpanzee iPSCs into hpIPCs. (A) scRNA-seq data of human and chimpanzee cells from iPSCs to day (d) 5 of
hpIPC differentiation, grouped by time point and split by species. Uniform manifold approximation and projection, UMAP. (B,C) PAX6 and OTX2 expression
across the hpIPC differentiation time points. Darker gray indicates greater expression. (D) Western blotting of human and chimpanzee differentiated iPSC
samples against TBR2 from day 0 to day 5 of differentiation. GAPDH is shown as the loading control. Images are representative of two replicates.
(E) Quantification of cells in the S, G1 and G2/M phases of the cell cycle from scRNA-seq data. (F) Heatmaps of ChIP-seq against TBR2 and H3K27ac in
day-5 hpIPCs from human and chimpanzee. Red indicates signals.
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Fig. 2. Differential gene expression in human and chimpanzee hpIPCs. (A) Schematic of iPSC differentiation followed by RNA-seq library generation and
analysis. Hippcampal NPC, hpNPC. (B) Volcano plot depicting ‘Human UP’ genes (right) and ‘Chimp UP’ genes (left) with a log2[fold change (FC)] threshold
of 1.5 and −1.5, respectively, and a P-value threshold of 0.05. (C) Top upstream regulators of the DEGs predicted by Ingenuity pathway analysis, ranked by
−log10P. (D) Heatmaps depicting the expression of genes predicted to be under the control of the transcription factors CREB1, FOXA2 and TBR2 or
predicted to play a role in embryonic development. The rows of the heatmaps indicate the transcript names, columns indicate the species, sample number
and replicate. For example, ‘HS1 Rep 1’ indicates Homo sapiens sample 1 replicate 1, and ‘PT2 Rep 2’ indicates Pan troglodytes sample 2 replicate 2.

data as predicted targets of all three transcription factors were also
found to be among the 2588 genes differentially expressed
between human and chimpanzee hpIPCs (Fig. 2D; Tables S2-S4).
The pathway analysis also determined that several of the
DEGs are involved in embryonic development (Fig. 2D;
Table S5). Overall, these findings indicate that previously
characterized neurodevelopmental gene regulatory networks are
utilized differently during human and chimpanzee hippocampal
development.
Human-specific chromatin accessibility patterns in hpIPCs

After identifying DEGs and the transcriptional networks that may be
involved, we sought to identify cis-regulatory differences between
the human and chimpanzee hpIPCs. To this end, we conducted
ATAC-seq on the hpIPCs from both species. We used the same
batches of differentiated iPSCs for the ATAC-seq as we did for the
RNA-seq (i.e. from the same batch of differentiation) and generated
100 bp long paired-end Illumina reads.
We first performed a human-centric analysis. We aligned the
ATAC-seq reads from all six cell lines to the respective reference
4
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neurodevelopment or neurodegenerative disease (Abrajano et al.,
2009; Hickey et al., 2019; Kamboh et al., 2019; Kolehmainen
et al., 2003; MacDermot et al., 2005; Mathys et al., 2019; Sin et al.,
2015; Taher et al., 2014). The ‘Chimp UP’ genes include
HIST1H3A, BCL2L2 and CLIC1, which have been reported to be
expressed in the hippocampus and are associated with sleep, AD
and neurite outgrowth (Averaimo et al., 2014; Datson et al., 2009;
Wei, 2020).
To understand the transcriptional programs driving these
differences in gene expression, we conducted an Ingenuity
pathway analysis. Three of the top five upstream regulators
predicted by the pathway analysis were the transcription factors
CREB1, FOXA2 and TBR2 (Fig. 2C). CREB1 is known to regulate
genes involved in the nervous system and neurodevelopment
(reviewed by Sakamoto et al., 2011), FOXA2 controls
dopaminergic neuronal development and disease (Kittappa et al.,
2007), and TBR2 plays a crucial role in cortical and hippocampal
neurogenesis and is the signature marker of the intermediate
progenitor cell population (Cipriani et al., 2016; Englund,
2005). This pathway analysis was consistent with the RNA-seq

genome assemblies (hg19 for the human cell lines, panTro5 for the
chimpanzee cell lines) and only retained uniquely mapped reads
with high mapping quality (Samtools q=10 filtering). Next, we
identified regions of accessible chromatin ( peaks; FDR<0.05) in
all three human cell lines. Only peaks replicated in all the three
human lines were retained. To carry out a proper comparison, we only
retained replicated human ATAC-seq peaks with orthologs in the
chimpanzee genome (see Materials and Methods; Fig. 3A).
This filtering ultimately resulted in 82,235 human ATAC-seq
peaks that were replicated in all the human cell lines and with
orthologs in the chimpanzee genome. These 82,235 regions were used
for downstream analysis. We found that the chromatin accessibility at
these regions was highly reproducible across all three human cell lines
(Fig. 3B).
Next, we quantified the ATAC-seq read depth for each of
the 82,235 regions and used DESeq2 to identify sites exhibiting
differential chromatin accessibility between the two species. In
total, we identified 3006 DA regions [FDR<0.05; log2(fold
change)>1.5 or <−1.5; Tables S6 and S7]. Of these regions,
92.3% were located at least 1 kb away from the closest transcription
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start site (TSS), suggesting that they could be putative enhancers,
whereas the remaining were putative promoters (Fig. 3C). As
expected, given that this analysis was performed with a humancentric approach, 90.1% of the DA peaks were significantly more
accessible in the human hpIPCs relative to chimpanzee hpIPCs
(‘Human UP’; Fig. 3C).
As TE insertions can be a source of cis-regulatory evolution, we
examined whether the DA regions were more likely to overlap with
a TE than those that were accessible to the same degree in both
species (non-DA; Fig. 3D; Tables S9 and S10). We observed that
1335/3006 (44.4%) DA regions overlapped a TE (Table S8). This is
significantly higher than what was observed for the non-DA peaks
(33.2% overlapped a TE; two-sided Fisher’s exact test, P<0.0001;
Fig. 3D). This indicates that chromatin regions with human-specific
accessibility are significantly more likely to be TE-derived than the
regions with accessibility levels conserved between human and
chimpanzee.
Next, we associated the nearest gene to each DA region and found
that TE-derived DA regions were significantly more likely to be
near a DEG relative to non-TE derived DA regions (two-sided

Fig. 3. Human-centric chromatin accessibility analysis. (A) Schematic of iPSC differentiation followed by ATAC-seq library generation and analysis.
(B) UCSC Genome Browser visualization of human ATAC-seq libraries (HS Reps 1, 2 and 3) aligned to hg19 genome assembly. (C) Distribution of the DA
peaks into enhancers or promoters, and into ‘Human UP’ (greater accessibility in humans) or ‘Chimp UP’ (greater accessibility in chimpanzees).
(D) DA chromatin regions (P<0.05, n=3006) are more likely to overlap with transposable elements (TEs) than non-DA regions (P>0.9, n=3006). (E) The 1335
TE-derived DA regions are more likely to be near a DEG, compared with DA regions that do not overlap a TE. *P<0.05; ****P<0.0001 (Fisher’s exact test).
(F) Distribution of the five major TE classes in the human genome, compared with their distribution among the TE-derived DA chromatin regions, and among
the TE-derived DA chromatin regions proximal to a DEG.
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Fisher’s exact test, P=0.016; Fig. 3E). Finally, we investigated
whether specific TE families were overrepresented among the
TE-derived DA regions and found enrichment for LTRs. Although
LTRs account for ∼16% of all human annotated TEs, they
represented 33.9% of the TEs overlapping DA regions in our
human-centric analysis (two-Sided Fisher’s exact test, P<0.0001;
Fig. 3F; Table S11). Of these enriched LTRs, 97.1% were ERVs.
Notably, 31.7% of the LTR-derived DA regions were located near a
DEG (two-sided Fisher’s exact test P<0.0001).
Taken together, these data indicate that there are TE-derived cisregulatory elements that have significantly greater accessibility in
humans than in chimpanzees during hippocampal neurogenesis.
These TE insertions preceded the human-chimpanzee split, but the
difference in accessibility is species specific, suggesting that the cooption into gene regulatory networks took place after the humanchimpanzee divergence.

Development (2022) 149, dev200413. doi:10.1242/dev.200413

Chimpanzee-specific chromatin accessibility patterns in
hpIPCs

We repeated the ATAC-seq analysis as described above, but this
time with a chimpanzee-centric approach. We started from a set of
72,211 peaks found to be replicated in all the three chimpanzee lines
and with orthologs in both species (Fig. 4A,B). With this approach,
we identified 3806 ATAC-seq peaks as being DA between human
and chimpanzee [FDR<0.05; log2(fold change)>1.5 or <−1.5;
Tables S16 and S17], 82% of which displayed greater accessibility
in chimpanzee compared with humans (i.e. ‘Chimp UP’; Fig. 4C).
Similar to what we observed with the human-centric analysis,
97.9% of the 3806 DA regions were putative enhancers
(distance>1 kb from TSS; Fig. 4C).
As seen in the human-centric analysis, chimpanzee-specific DA
peaks were more likely to be TE derived than those that were
similarly accessible across species (two-sided Fisher’s exact test,

Fig. 4. Chimpanzee-centric chromatin accessibility analysis. (A) Schematic of iPSC differentiation followed by ATAC-seq library generation and analysis.
(B) UCSC Genome Browser visualization of human ATAC-seq libraries (PT Reps 1, 2 and 3) aligned to hg19 genome assembly. (C) Distribution of the DA
peaks into enhancers or promoters, and into ‘Human UP’ (greater accessibility in humans) or ‘Chimp UP’ (greater accessibility in chimpanzees). (D) DA
chromatin regions (P<0.05, n=3806) are more likely to overlap with transposable elements than other accessible regions (P>0.9, n=3806). (E) Distribution of
DA regions that overlap a TE and proximity to genes differentially expressed between human and chimpanzee hpIPCs. ns, not significant; ****P<0.0001
(Fisher’s exact test). (F) Distribution of the five major TE classes in the chimpanzee genome, compared with their distribution among the 1410 TE-derived DA
chromatin regions. (G) Breakdown of the 20 miscellaneous TEs represented in the 1410 TE-derived DA chromatin regions. (H) Distribution of SVA family of
TEs in the human genome compared with their distribution in the TE-derived DA chromatin regions (n=16).
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P<0.0001; Fig. 4D; Tables S18-S20). Of the chimpanzee DA
regions, 37.1% overlapped an annotated chimpanzee TE, compared
with only 28.1% of the non-DA regions (two-sided Fisher’s exact
test, P<0.0001; Fig. 4D). However, the TE-derived enhancers in this
chimpanzee-centric analysis were no more likely to be located near
DEGs than the non-TE derived ones (Fig. 4E).
We found enrichment for LTRs, which account for approximately
16% of the chimpanzee TEs but represented 36.1% of the TEderived DA regions (two-sided Fisher’s exact test, P-value<0.0001;
98.2% were ERVs; Fig. 4F; Table S21), and SVAs, which account
for just 0.25% of annotated chimpanzee TEs but represented 1.1%
of the TE-derived DA regions (two-sided Fisher’s exact test,
P<0.0001, Fig. 4G; Table S23). In particular, the SVA-B and SVAC subfamilies were the most enriched (Fig. 4H). Taken together,
these data indicate that chimpanzee ERV and SVA transposons were
co-opted into regulatory elements important for the developing
chimpanzee hpIPCs.
Genomic features underlying species-specific LTR
enrichment at hpIPC enhancers

We aimed to further investigate genomic features potentially
underlying the LTR enrichment among the DA hippocampal
progenitor regions. To this end, we conducted a motif analysis using

Development (2022) 149, dev200413. doi:10.1242/dev.200413

the MEME suite (Bailey et al., 2015). Binding motifs for CTCF and
EGR2 were detected as being enriched in the LTR-derived DA
regions identified from both the human-centric and chimpanzeecentric analyses (Fig. 5A,C). EGR2 is an early response gene
involved in learning and memory, in the brain response to stimuli
and in hippocampal synaptic plasticity (Cheval et al., 2012;
Mukherjee et al., 2021; Poirier et al., 2007). CTCF, a well-known
regulator of chromatin structure, has been implicated in various
neurodevelopmental disorders (reviewed by Davis et al., 2018).
We identified 63 DEGs located near the human-enriched LTRs
(Fig. 5B; Table S12). These included GLUL, a glutamine synthetase
hypothesized to provide neuroprotection in AD patients, (Kohane
and Wood, 2021 preprint) and DLK1, a Notch ligand involved in
sub-ventricular zone neurogenesis (Ferrón et al., 2011), both of
which are upregulated in human hpIPCs compared with chimpanzee
hpIPCs.
We identified 34 DEGs located near the chimp-enriched LTRs
(Fig. 5D; Table S22). For the chimp-centric analysis, the DEGs
located near TE-derived enhancers with species-specific
accessibility included HIST1H3A and MTRNR2L8, which were
highly upregulated in the chimpanzee and human hpIPCs,
respectively (Fig. 5D). Importantly, HIST1H3A has been
associated with autism spectrum disorders and sleep deprivation

Fig. 5. LTRs are enriched among human and chimpanzee DA transposons. (A) Distribution of LTRs compared with non-LTRs in the human genome and
in the 1335 human TE-derived DA regions, with predicted binding motifs. (B) Differentially expressed genes close to the human-enriched DA LTRs.
(C) Distribution of LTRs compared with non-LTRs in the chimpanzee genome and in the 1410 chimpanzee TE-derived DA regions, with predicted binding
motifs. (D) Differentially expressed genes close to the chimpanzee-enriched DA LTRs.
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(Crawley et al., 2016; Wei, 2020), whereas MTRN2L8 has been
reported as being upregulated in AD patients (Mathys et al., 2019).
Human-specific SVAs play a major role in hippocampal
neurogenesis

As mentioned earlier, the chimpanzee-centric analysis also
identified SVA transposons as being enriched within chimpanzeespecific enhancers (Fig. 6A; Table S23). These SVAs were enriched
for the identified binding motifs of the neurodevelopmental factors
ASCL1, ZIC1 and KLF8 (Andersen et al., 2014; Aruga, 2004;
Yi et al., 2014), as well as the JUN/FOS-AP-1 dimer, which is a
known enhancer activator (Raivich, 2008; Raivich and Behrens,
2006) (Fig. 6A).
It is important to note that all the analyses shown so far were
exclusively based on genomic sites with characterized orthologs in
both species, to ensure an equivalent comparison. However, nearly
2000 SVA copies, including the entire SVA-E and SVA-F
subfamilies, are exclusive to the human genome. Given that
previous studies found that SVAs are highly enriched in active
enhancers and promoters of the human hippocampus (Trizzino
et al., 2018), we sought to investigate this further. We focused on the
SVA copies exclusively present in the human genome and not in any
other primate genome (hereafter human-specific SVAs). We
performed sequence-based motif analysis for all the humanspecific SVAs and identified the binding motif for the hpIPC
signature factor TBR2 as the most enriched (P=10−2103; Fig. 6B).
Motifs for other transcription factors associated with hippocampal
neurogenesis and function were also recovered (SMAD3, VDR and
PLAG1; Fig. 6B).
Next, we annotated all genes found within 50 kb from each
human-specific SVA. A total of 2216 genes were recovered using
this approach. We performed pathway analysis on this set of genes
and found that ‘melatonin degradation’ and ‘nicotine degradation’
were the two most significantly enriched pathways (P=7.6×10−6
and P=2.5×10−5, respectively; Fig. 6C) and PHF8 was recovered as
the top upstream regulator for the gene network (Fig. 6C). Notably,
both melatonin and nicotine degradation pathways are strongly
active in the human hippocampus. PHF8 is a histone demethylase
that contributes to the regulation of mTOR. The mTOR pathway is
hyperactive in the human hippocampus where it regulates the
protein synthesis-dependent plastic changes underlying learning
and memory (Bekinschtein et al., 2007; Fortress et al., 2013; Graber
et al., 2013). Mutations in the PHF8 gene cause cognitive
impairment and intellectual disability (Chen et al., 2018).
Therefore, we sought to determine the contribution of humanspecific SVAs to the TBR2-mediated gene regulatory network in
human hpIPCs. Using our ATAC-seq data, we identified 1816
human SVAs as accessible in human hpIPCs (Fig. 6D). Of these,
nearly a quarter (434) displayed high accessibility, whereas 1382
were moderately accessible (Fig. 6D). Next, we used ChIP-seq to
profile TBR2 binding in two human lines at day 5 of hpIPC
differentiation. As with the previous sequencing experiments, we
generated 100 bp long paired-end reads and only retained uniquely
mapping high-quality reads (Samtools q=10 filtering) in order to
maximize the chance to properly map reads on repetitive regions.
This experiment revealed that 739 of the accessible SVAs
showed TBR2 signals in the two human lines (Fig. 6D;
Table S13). Notably, 257 (48.3%) of the TBR2-bound SVAs were
human specific. (Fig. 6E; Table S14). TBR2-bound human-specific
SVAs were located near 37 genes that our RNA-seq analysis
identified as being differentially expressed between human and
chimpanzee (Fig. 6F; Table S15). These genes include VPS13B
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(upregulated in humans), which is responsible for a rare
developmental disease known as Cohen syndrome (Kolehmainen
et al., 2003); NR4A2 (downregulated in humans), which has been
implicated in neurodevelopmental language impairment (Reuter
et al., 2017); DHX40 (downregulated in humans), which is
implicated in AD (Taher et al., 2014); and E2F1 (upregulated in
humans), which is a cell-cycle regulator associated with several
neurodegenerative diseases such as AD (Zhang et al., 2010).
In summary, these data support a model in which human-specific
SVAs provided a substrate for binding sites of TBR2 and other
important hippocampal regulators. Therefore, it is likely that they
were co-opted in the gene regulatory networks that are active during
hippocampal neurogenesis, which led to human-specific regulation
of key genes.
CRISPR-mediated SVA repression has massive
repercussions on global gene expression

To further assess the contribution of SVA transposons to the gene
regulation of hpIPCs, we leveraged CRISPR interference to
simultaneously repress most of the active SVAs. We used NCCIT
cells treated with retinoic acid (RA) as the experimental system for
this purpose. The NCCIT cell line is derived from embryonal
carcinoma and thus exhibits a gene expression signature highly
similar to human embryonic stem cells (Fuentes et al., 2018;
Barnada et al., 2022). Importantly, NCCITs treated for 7 days with
RA differentiate into intermediate neural progenitor-like cells
expressing both PAX6 and TBR2 (Mandal et al., 2015; Fig. 7A).
RNA-seq data [transcripts per million (TPMs)] suggest very strong
correlation between RA-treated NCCITs and human day-5 hpIPCs
(Pearson correlation P<2.2×10−16, R=0.99). We cloned a stable
NCCIT line with a permanently incorporated doxycyclineinducible, catalytically dead Cas9 fused to a repressive KRAB
domain (dCas9-KRAB). The KRAB domain deposits repressive
histone methylation (H3K9me3) to the regions targeted by dCas9
via single guide RNAs (sgRNAs). Into this same line, we also
permanently knocked in two sgRNAs that are able to target >80% of
all SVAs (Pontis et al., 2019). Hereafter, we refer to the RA-treated
CRISPR line as RA-NCCITs. Remarkably, exposing the RANCCITs to doxycycline for 72 h was sufficient to induce dCas9
activation (Fig. 7B) and the deposition of the repressive H3K9me3
on over 2500 previously unmethylated SVAs (Fig. 7C). We next
performed RNA-seq on the RA-NCCITs with or without
doxycycline treatment (three replicates per condition). First, we
observed that the genome-wide expression levels (TPMs) of the
RA-NCCITs were highly correlated with those of the iPSC-derived
human hpIPCs (Pearson correlation=0.93; P<2.2×10−16). This
indicates that RA-treated NCCITs are appropriate to model hpIPCs.
Then, we compared the expression levels of the RA-NCCITs with
or without doxycycline treatment and identified 5795 DEGs
(FDR<0.05; Fig. 7D; Table S24). Of these genes, 677 were
previously identified as differentially expressed upon comparing
human with chimpanzee hpIPCs (Fig. 7E; Table S25). In other
words, the expression of over a quarter (26.1%) of the genes that
exhibited a human-specific expression signature in hpIPCs seem to
be under the control of SVA transposons. Importantly, one of these
genes is FOXP2, which has been associated with the evolution of
language and is implicated in several speech disorders (Enard,
2011; Liégeois et al., 2016; MacDermot et al., 2005).
As the guide RNAs used for this experiment were originally
designed to target a DNA sequence shared by the SVAs with the
LTR5H family (Pontis et al., 2019), we restricted the analysis to the
genes that are associated with human SVAs (i.e. only considering
8
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Fig. 6. Human-specific SVAs bind TBR2 and influence neurodevelopment. (A) The SVAs enriched within the chimpanzee DA peaks are enriched for
binding motifs of neurodevelopmental transcription factors KLF8, ZIC1 and ASCL1, as well as the AP-1 dimer. (B) Human SVAs are enriched for the binding
motif of TBR2. (C) Genes proximal to human-specific SVAs are predicted to be regulated by neurodevelopmental transcription factors and function in
important neuronal pathways. (D) In humans, 1816 SVAs exhibit ATAC-seq signal in hpIPCs (red, signal; white, noise) and, of these, 739 exhibit a TBR2
ChIP signal (black, signal; yellow, background). (E) Breakdown of 739 accessible, TBR2-bound SVAs that are human specific or conserved in chimpanzees.
(F) Differentially expressed genes close to the human-specific TBR2-bound SVAs.
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Fig. 7. CRISPR interference of human SVAs. (A) Treating NCCITs with RA for 7 days led to the induction of TBR2 and PAX6 expression, as shown by
RT-qPCR. (B) Treating the RA-NCCIT stable CRISPR line for 72 h with doxycycline (dox) led to dCas9 activation, as shown in the Cas9 immunoblot. Images
are representative of two replicates. (C) dCas9 activation resulted in the deposition of H3K9me3 at most human SVAs as shown in the H3K9me3 ChIP-seq
heatmap. (D) Volcano plot depicting genes differentially expressed upon doxycycline treatment. (E) Venn diagram showing overlap between genes that are
differentially expressed between human and chimpanzee hpIPCs and between RA-NCCITs with or without doxycycline treatment (i.e. with and without SVA
repression). (F) Pie chart illustrating the fraction of TBR2-controlled genes that are differentially expressed upon SVA repression in RA-NCCITs.
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the genes that represent the closest gene to an annotated SVA;
hereafter SVA genes). By doing so, we found 611 SVA genes as
differentially expressed in RA-NCCITs upon SVA repression. Of
these, 90 were previously identified as differentially expressed upon
comparing human with chimpanzee hpIPCs. Thus, the expression
of these 90 genes can be bona fide considered to be directly
regulated by SVA-derived enhancers in both primary hippocampal
progenitors and in the NCCIT cell line. Remarkably, the large
majority of these genes (72.5%) had decreased expression upon
SVA repression. These include SOX2, FGF2, PRDM1, NTRK2 and
TFAP2B.
Finally, we examined the genes previously identified as being
near a TBR2-bound human-specific SVA in iPSC-derived hpIPCs
and found that nearly a third of them lose expression in RA-NCCITs
upon SVA repression (Fig. 7F). In summary, our functional
experiments indicate a widespread role for human-specific SVA
transposons as cis-regulatory elements during hippocampal
neurogenesis.
DISCUSSION

The hippocampus is susceptible to specific neurodegenerative
disorders such as AD but may have also played an important role
in the evolution of human cognition. Spatial memory, which is
attributed to the hippocampus, may have contributed to the
geographic expansion of ancient humans. Characterizing the
human-specific gene regulatory networks of hippocampal
development provides insight into its role in human evolution.
Although there is no consensus on whether the cognitive phenotypes
seen in AD are uniquely specific to humans, understanding the unique
properties of the human hippocampus may lead the way to potential
treatments. Thus, the work described here is relevant both in terms of
evolutionary developmental biology and evolutionary medicine.
To study the evolution of the human hippocampus from a
developmental standpoint, we investigated the extent to which TEs
contributed to gene expression profiles of human and chimpanzee
hpIPCs. TEs account for nearly 50% of the human genome and
many elegant studies have established that at least a fraction of TEs
can regulate host genes in humans and other primates (Chuong
et al., 2013, 2016; Cosby et al., 2021; del Rosario et al., 2014; Du
et al., 2016; Fuentes et al., 2018; Jacques et al., 2013; Judd et al.,
2021; Lynch et al., 2011, 2015; Mika et al., 2021; Modzelewski
et al., 2021; Okhovat et al., 2020; Rayan et al., 2016; Schmidt et al.,
2012; Sundaram et al., 2014; Trizzino et al., 2017, 2018; Ward et al.,
2018; Xie et al., 2013).
HpIPCs are a transient progenitor population during a crucial
developmental stage in the sub-ventricular zone of both the
hippocampus and neocortex (Bulfone et al., 1999; Cipriani et al.,
2016; Englund, 2005; Kimura et al., 1999), and there is a consensus
that this progenitor population may have played a role in the
evolution of brain volume in mammals (Florio and Huttner, 2014;
Martínez-Cerdeño et al., 2006). To study the developmental
evolution of human hpIPCs, we leveraged a comparative approach
centered on differentiating human and chimpanzee iPSCs into a
neuronal population that closely recapitulates differentiation into
hpIPCs, as demonstrated by the high expression of signature
markers such as TBR2 and PAX6.
The transcriptomes of human and chimpanzee hpIPCs have not
been previously compared, largely due to the limited availability of
primary tissue. Here, we carried out this comparison using our
iPSC-derived system and identified profound differences between
the two species, with over 2500 genes differentially expressed at this
stage. These genes include several that were previously associated
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with cognitive function, language, neurodevelopment and
neurodegeneration, many of which are upregulated in humans
relative to the chimpanzee (e.g. MTRNR2L8, DHX40, VPS13B,
WDFY2 and PURB).
We demonstrate that species-specific enhancers significantly
contributed to the gene expression differences that we identified.
This is consistent with recent studies that used primary brain tissues
from several species to profile species-specific cis-regulatory activity
in mammals (Emera et al., 2016; Reilly et al., 2015). Importantly, we
found that these species-specific enhancers are enriched for young
transposable elements. Several studies have identified evolutionarily
young L1 long interspersed nuclear elements (LINEs) as active in the
brain during different developmental stages, suggesting that they
could serve as alternative promoters for many genes involved
in neuronal functions (Coufal et al., 2009; Jönsson et al., 2019;
Sur et al., 2017; Thomas et al., 2012; Zhao et al., 2019). Here, we
identified other young transposable elements, ERVs and SVAs, as
regulators of IPC gene expression. The identification of ERVs as
candidate enhancers in human and chimpanzee IPCs is consistent
with previous studies that demonstrated that ERVs heavily impact
gene regulatory programs during the immune response (Chuong
et al., 2013, 2016), in pluripotency maintenance and development
(Coluccio et al., 2018; Fuentes et al., 2018; Miao et al., 2020), in
the mammalian placenta (Lynch et al., 2011, 2015; Mika et al.,
2021), in the primate liver (Trizzino et al., 2017) and in many cancer
types (Ito et al., 2020; Ivancevic and Chuong, 2020; Shah et al.,
2021). Similar to the L1s, the ERVs also possess a well-defined
cis-regulatory architecture (e.g. they have their own promoter), and
this may have played a role in the co-option of these TEs as
functioning cis-regulatory elements.
The SVAs are particularly interesting from a human evolution
standpoint, given that half the known copies are exclusively present
in our species. Moreover, SVAs are among the few transposable
elements that still exhibit active transposition in the human genome.
We and others have previously revealed that SVAs can be sources of
enhancers in primates (Playfoot et al., 2021; Pontis et al., 2019;
Trizzino et al., 2017, 2018). The repression of some SVAs by
specific zinc-finger proteins at specific stages of neuronal
development is also a crucial mechanism for successful
neurogenesis (Playfoot et al., 2021; Pontis et al., 2019; Turelli
et al., 2020). Here, we demonstrate that SVAs are pervasive
regulators of hippocampal neurogenesis and they act as enhancers in
the hpIPC population. By using CRISPR interference, we show that
repressing hundreds of normally ‘de-repressed’ SVAs alters the
expression of thousands of genes. Intriguingly, our CRISPR
interference experiments revealed that global SVA repression
leads to the attenuation of the expression levels of over a quarter
of the ∼2500 genes previously identified as showing humanspecific expression in hpIPCs. These include crucial
neurodevelopmental regulators such as FOXP2, HAND2, MEF2C,
SOX2 and SOX4. In normal conditions, these genes are more highly
expressed in humans relative to in chimpanzees, but upon SVA
repression, these differences were diminished.
In conclusion, our findings indicate that the development of
hippocampal neurons has been profoundly affected by the
domestication of young transposable elements. These young TEs
have been co-opted as functional enhancers and promoters and
ultimately rewired the expression of hundreds of crucially important
neuroregulators in the developing human hippocampus. The
human-specific gene expression and the associated TE-derived
enhancers that we identified here may play important roles in both
human evolution and neurodegenerative disease.
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Antibodies

The following antibodies were used in this study: anti-TBR2 (15 µg per
ChIP, Abcam, ab216870), anti-H3K9me3 (3 µg per ChIP, Abcam, ab8898),
anti-H3K21ac (3 µg per ChIP, Abcam, ab4729), anti-TBR2 (1:500 for
western blotting, Santa Cruz Biotechnology, sc-293481), anti-GAPDH
(1:1000 for western blotting, Cell Signaling Technology, 5174), HRPconjugated anti-rabbit (1:10,000 for western blotting, Cell Signaling
Technology, 7074S) and HRP-conjugated anti-mouse (1:10,000 for
western blotting, Cell Signaling Technology, 7076S).
Human and chimpanzee iPSC cultures

The human male iPSC line denoted as SV20 was obtained from the
University of Pennsylvania, where it was generated, and validated by the
expression of pluripotency markers and differentiation into various cell
types in multiple studies (Pagliaroli et al., 2021; Pashos et al., 2017; Yang
et al., 2015; Zhang et al., 2015). The human female iPSC line GM 23716
was obtained from the Coriell Institute for Medical Research (Camden, NJ,
USA) and validated by the expression of pluripotency markers and
differentiation into cranial neural crest cells in a previous study (Pagliaroli
et al., 2021). The human female iPSC line 21792 and all three chimpanzee
iPSC lines were obtained from the laboratory of Yoav Gilad at the University
of Chicago and validated in previous studies (Gallego Romero et al., 2015;
Ward et al., 2018).
The iPSC lines were expanded in feeder-free, serum-free mTeSR1
medium (STEMCELL Technologies). Cells were passaged ∼1:10 at 80%
confluency using ReLeSR (STEMCELL Technologies) and small cell
clusters (50-200 cells) were subsequently plated on tissue culture dishes
coated overnight with Geltrex LDEV-Free hESC-qualified reduced growth
factor basement membrane matrix (Thermo Fisher Scientific).
hpIPC differentiation

The iPSC lines were differentiated into hpIPCs as previously described
(Yu et al., 2014). Three batches consisting of one human and one
chimpanzee iPSC line each were cultured until ∼50-70% confluence was
reached, and then treated with the hpIPC medium for 5 days prior to
collection for RNA-seq, ATAC-seq, ChIP-seq or immunofluorescence. The
hpIPC medium consisted of Dulbecco’s modified Eagle medium (DMEM)/
F12 (Invitrogen), 0.5× N2 (Invitrogen), 0.5× B27 (Invitrogen), DKK1
(0.5 μg/ml, BioLegend), cyclopamine (1 μM, LC Labroatories), Noggin
(0.5 μg/ml, BioLegend), SB431542 (10 μM, Selleck Chemicals) and the
antibiotics penicillin/streptomycin (1× from 100× stock, Gibco).
Western blotting

For western blotting of total lysates, cells were harvested and washed three
times in 1× PBS and lysed in RIPA buffer (50 mM Tris-HCl pH 7.5,
150 mM NaCl, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS, 500 µM
dithiothreitol) with protease inhibitors (Sigma-Aldrich). Approximately
20 μg of whole cell lysates were loaded in Novex WedgeWell 4-20% TrisGlycine Gels (Invitrogen) in a Tris-Glycine-SDS buffer (Invitrogen) and
separated by gel electrophoresis (SDS-PAGE). The proteins were then
transferred to Immun-Blot PVDF membranes (Thermo Fisher Scientific) for
antibody probing. Membranes were incubated with 10% bovine serum
albumin in TBS with 3% Tween 20 (TBST) for 30 min at room temperature
(RT), then incubated for variable times with suitable antibodies diluted in
5% bovine serum albumin in 1× TBST, washed with TBST and incubated
with a dilution of 1:10,000 of the secondary antibody for 1 h at RT.
The antibody was visualized using Super Signal West Dura Extended
Duration Substrate (Thermo Fisher Scientific) and imaged with Amersham
Imager 680.

real-time quantitative PCR (RT-qPCR) reaction with 0.1 μM of each primer,
10 μl of PowerUp SYBR Green Master Mix (Applied Biosystems) in a final
volume of 20 μl, using QuantStudio 3 Real-Time PCR System (Applied
Biosystems). Thermal cycling parameters were set as following: 3 min at
95°C, followed by 40 cycles of 10 s at 95°C, 20 s at 63°C, followed by 30 s
at 72°C. Each sample was run in triplicate. 18S rRNA was used as a
normalizer.
ChIP-seq

Samples from different conditions were processed together to prevent batch
effects. Approximately 15 million cells were cross-linked with 1%
formaldehyde for 5 min at RT, quenched with 125 mM glycine, harvested
and washed twice with 1× PBS. The pellet was resuspended in ChIP lysis
buffer (150 mM NaCl, 1% Triton X-100, 0.7% SDS, 500 μM dithiothreitol,
10 mM Tris-HCl, 5 mM EDTA) and chromatin was sheared to an average
length of 200-500 bp, using a Covaris S220 Ultrasonicator. The chromatin
lysate was diluted with SDS-free ChIP lysis buffer. For ChIP-seq, 10 µg of
antibody (3 µg for H3K27ac) was added to 5 µg of sonicated chromatin
along with Dynabeads Protein A magnetic beads (Invitrogen) and incubated
at 4°C overnight. On day 2, beads were washed twice with each of the
following buffers: mixed micelle buffer (150 mM NaCl, 1% Triton X-100,
0.2% SDS, 20 mM Tris-HCl, 5 mM EDTA, 65% sucrose), buffer 500
(500 mM NaCl, 1% Triton X-100, 0.1% sodium deoxycholate, 25 mM
HEPES, 10 mM Tris-HCl, 1 mM EDTA) and LiCl/detergent wash buffer
(250 mM LiCl, 0.5% sodium deoxycholate, 0.5% NP-40, 10 mM Tris-HCl,
1 mM EDTA). A final wash was performed with 1× Tris-EDTA (TE) buffer.
Finally, beads were resuspended in 1× TE buffer containing 1% SDS and
incubated at 65°C for 10 min to elute immunocomplexes. Elution was
repeated twice, and the samples were further incubated overnight at 65°C to
reverse cross-linking, along with the untreated input (5% of the starting
material). On day 3, after treatment with 0.5 mg/ml proteinase K for 1 h at
65°C, DNA was purified with Zymo ChIP DNA Clear Concentrator kit and
quantified with QUBIT (Invitrogen).
For all ChIP-seq experiments, barcoded libraries were made with NEB
ULTRA II DNA Library Prep Kit for Illumina (New England Biolabs) and
sequenced on Illumina NextSeq 500, producing 100 bp paired-end reads.
ChIP-seq analyses

After removing the adapters with TrimGalore! (https://www.bioinformatics.
babraham.ac.uk/projects/trim_galore/), the sequences were aligned to the
reference hg19, using Burrows–Wheeler Alignment tool (BWA), with
the MEM algorithm (http://bio-bwa.sourceforge.net/bwa.shtml). Uniquely
mapping aligned reads were filtered based on mapping quality (MAPQ>10)
to restrict our analysis to higher quality and likely uniquely mapped reads,
and PCR duplicates were removed. We called peaks for each individual
using MACS2 (Heinz et al., 2010) (H3K27ac) or Homer (http://homer.ucsd.
edu/homer/) at 5% FDR with default parameters.
RNA-seq

Cells were lysed in TRI-reagent and total RNA was extracted using Quick
RNA Miniprep kit (Zymo Research) according to the manufacturer’s
instructions. RNA was further quantified using the DeNovix DS-11
Spectrophotometer and the RNA integrity was checked on Bioanalyzer
2100 (Agilent). Only samples with an RNA integrity number above 8.0 were
used for transcriptome analysis. RNA libraries were prepared using 1 μg of
total RNA input using NEBNext Poly(A) mRNA Magnetic Isolation
Module, NEBNext Ultra II Directional RNA Library Prep Kit for Illumina
and NEBNext Ultra II DNA Library Prep Kit for Illumina according to the
manufacturer’s instructions (New England Biolabs).
scRNA-seq

Real-time quantitative PCR

Cells were lysed in TRI-reagent (Invitrogen) and RNA was extracted using
the Direct-zol RNA MiniPrep kit (Zymo Research). Approximately 600 ng
of template RNA was retrotranscribed into cDNA using RevertAid first
strand cDNA synthesis kit (Thermo Fisher Scientific) according to the
manufacturer’s directions. Approximately 15 ng of cDNA was used for each

Cells from both species at each time were first incubated with Accutase
(STEMCELL Technologies) at 37°C for 7 min. The cells were collected
with DMEM/F12 and centrifuged for 5 min at 150 g. The cells were
resuspended in 10% fetal bovine serum (Fisher Scientific) in DMEM and
strained with a 40 µm cell strainer to create a single-cell suspension. After
confirming >90% viability with a Countess III (Invitrogen), the cells
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scRNA-seq analyses

10× Cell Ranger (Zheng et al., 2017) was used to demultiplex and map the
scRNA-seq data, with the tools cellranger multi and cellranger mkfastq.
Seurat 4 (Hao et al., 2021) was used for individual analysis of scRNA-seq
data, as well as integration of human and chimpanzee datasets. The human
genes used to classify the cells into the G1/S/G2/M phases of the cell cycle
were obtained from https://github.com/hbctraining/scRNA-seq/blob/
master/lessons/06_SC_SCT_and_integration.md.
RNA-seq analyses

After removing the adapters with TrimGalore!, Kallisto (Bray et al., 2016)
was used to count reads mapping to each gene. We analyzed differential
gene expression levels with DESeq2 (Love et al., 2014), with the following
model: design=∼condition, where condition indicates either Human or
Chimpanzee.
ATAC-seq

For ATAC-Seq experiments, 50,000 cells per condition were processed as
described in the original ATAC-seq protocol paper (Buenrostro et al., 2013).
ATAC-seq data were processed with the same pipeline described for ChIPseq, with one modification: all mapped reads were offset by +4 bp for the
forward-strand and −5 bp for the reverse-strand. Peaks were called using
MACS2 (Zhang et al., 2008).
Generation of the NCCIT-dCas9KRAB-SVAsgRNA stable cell line

This cell line was generated in our recent study (Barnada et al., 2022).
Briefly, dCas9-KRAB was cloned into a piggyBac transposon containing
ampicillin and puromycin resistance, which was obtained from Raquel
Fueyo at Stanford University. The piggyBac dCas9-KRAB doxycyclineinducible plasmid and a piggyBac transposase (Cell Signaling Technology)
were transfected into NCCIT cells (American Type Culture Collection) at
∼70% confluency using a 6:1 ratio of Fugene HD (Promega) for 48 h in
ATCC-formulated RPMI medium (American Type Culture Collection).
Two days post-transfection, the medium was changed and the transfected
cells were selected using 1 µg puromycin in 1 ml medium. A piggyBac
transposon plasmid containing two sgRNAs (SVAsgRNA1, 5′CTCCCTAATCTCAAGTACCC-3′, and SVAsgRNA2, 5′-TGTTTCAGAGAGCACGGGGT-3′; Integrated DNA Technologies) targeting ∼80% of
all annotated SVAs in humans (Pontis et al., 2019) and a piggyBac
transposase were transfected into the NCCIT-dCas9KRAB cells using a 6:1
ratio of Fugene HD for 48 h in ATCC-formulated RPMI medium. Two days
post-transfection, the medium was changed and the transfected cells were
selected using 400 µg geneticin in 1 ml of medium in addition to 1 µg
puromycin in 1 ml medium. The NCCIT-dCas9KRAB-SVAsgRNA cell
line was maintained in ATCC-formulated RPMI medium supplemented
with 10% tetracycline-free fetal bovine serum (Omega Scientific), 1%
L-glutamine, 1 µg/ml puromycin and 400 µg/ml geneticin and incubated at
5% CO2, 20% O2 at 37°C.
RA-induced neuronal differentiation and CRISPR interference of
NCCIT-dCas9KRAB-SVAsgRNA cells

The NCCIT-dCas9KRAB-SVAsgRNA cells, at ∼20% confluency, were
treated with 10 µM RA (Sigma-Aldrich) in 10 ml medium for 1 week to
induce neuronal differentiation. At day 4, the medium was refreshed and the
cells were additionally treated with 2 µg doxycycline in 1 ml of medium for
3 days. The cells were collected on day 7 of RA treatment (day 3 of
doxycycline treatment) for RT-qPCR and genomic experiments. Expression
of the doxycycline-inducible dCas9 was verified via western blotting.
Statistical and genomic analyses

All statistical analyses were performed using R v3.3.1 or Graphpad Prism
version 9.2.0 for Mac OS X. BEDTools v2.27.1 (Quinlan and Hall, 2010) was

used for genomic analyses. Pathway analysis was performed with Ingenuity
Pathway Analysis Suite (QIAGEN, https://www.qiagenbioinformatics.com/
products/ingenuity-pathway-analysis). Motif analyses were performed using
the MEME suite (Bailey et al., 2015), and specifically with the MEME-ChIP
application. FASTA files of the regions of interest were produced using
BEDTools v2.27.1. Shuffled input sequences were used as background.
E-values<0.001 were used as threshold for significance. Orthologous ATACseq regions were identified using the University of California Santa Cruz
(UCSC) Genome Browser tool LiftOver.
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mechanism integrating inputs from extracellular signals to activate hippocampal
stem cells. Neuron 83, 1085-1097. doi:10.1016/j.neuron.2014.08.004
Arnold, S. J., Huang, G.-J., Cheung, A. F. P., Era, T., Nishikawa, S.-I.,
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